Works citing this work

4 works

Work: NLRP3 inflammasome in cancer and metabolic diseases

1. NLRP3 inflammasome-based therapies by natural products: a new development in the context of cancer therapy

   Hamza Abu Owida, Ahmed Abed, Farag M. A. Altalbawy +7

   Review articleInflammasome and immune disordersNaunyn-Schmiedeberg s Archives of Pharmacology20251 citations

   ABIABI:AkademIndex/openalex/2025.review-article.000073

2. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo

   Jinqian Mao, Yunfei Chen, Qiushuo Zong +10

   ArticlePhytochemistry and Bioactivity StudiesFrontiers in Immunology20240 citations

   ABIABI:AkademIndex/openalex/2024.article.000748

3. Non-coding RNAs as a Critical Player in the Regulation of Inflammasome in Inflammatory Bowel Diseases; Emphasize on lncRNAs

   H. Abed, Enwa Felix Oghenemaro, Aziz Kubaev +7

   Review articleCancer-related molecular mechanisms researchCell Biochemistry and Biophysics20240 citations

   ABIABI:AkademIndex/openalex/2024.review-article.000134

4. Treatment of Parkinson’s Disease with an Anti-Inflammasome NLRP3 Inhibitor Derived from a Natural Product

   Wenqian Li, Jiu‐liang Zhang, Qiang Chen +13

   ArticleInflammasome and immune disordersACS Pharmacology & Translational Science20250 citations

   ABIABI:AkademIndex/openalex/2025.article.009063